1 / 34

Main questions on HIV persistence and on obstacles to HIV eradication

Toward an HIV cure: Insight into residual viral replication, establishment of HIV reservoirs and understanding mechanism of persistence. Main questions on HIV persistence and on obstacles to HIV eradication. Jean-Pierre Routy M.D. McGill University Montreal.

bern
Download Presentation

Main questions on HIV persistence and on obstacles to HIV eradication

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Toward an HIV cure: Insight into residual viral replication, establishment of HIV reservoirs and understanding mechanism of persistence Main questions on HIV persistence and on obstacles to HIV eradication Jean-Pierre Routy M.D. McGill University Montreal

  2. IAS international working group:

  3. Even best candidates are not cured by HAART: “The Toronto patient” • Early infection treatment, plasma VL < 50 copies, x 10,5 years • HIV DNA undetectable from blood and sigmoid tissues at the time of the analysis • HAART discontinuation Chun, Kovacs, Fauci AIDS 2010; 24:2803

  4. The Berlin patient: Treated for acute myeloid leukemia by allo-stem cell transplatation

  5. “The Berlin patient”

  6. ABC news December 17, 2010“A risky and inconvenient method” ABC News December 17, 2010

  7. What does cure mean ? • Sterilizing cure: • No genetic material can be found in the host, HIV infection is eradicated • “Pax romana” or functional cure: • Some HIV genetic material remains in the host, but the immune system fully controls viral replication in absence HAART

  8. Why HAART does not cure HIV ? • HAART only blocks HIV replication/entry • HAART does not kill infected cells: • The immune system should eliminate infected cells like • Persistence in long-lived cells • Integrated into the host cell nucleus • HIV DNA survives as long as the cell • 9% of our human genome is also made from old integrated retroviruses

  9. What do we know on HIV-infected cells under HAART ? • Hematopoietic cells +/- • Macrophages + • Microglia + • Memory CD4 T cells +++

  10. Heterogeneity of the infected memory CD4 T cells Central memory Transitional memory Naive Chomont et al Nat med 2009

  11. Why residual viremia persists with HAART (few copies only) ? • Ongoing low viral replication: • Not allowing drug resistance development • New cells been infected • Reservoir maintained by replenishment • Localization: • Lymphoid tissues • Anatomic sanctuaries: CNS • Lower antiretroviral drug penetration • More antiretroviral drugs should do better

  12. Residual plasma viremia and size of pro viral DNA in treated patients Reservoir size Viral load < 50 No correlation between CD4 and CD8 CD38 ceils and reservoir size Chun, Kovac, Fauci et al JID 2011; 204:135

  13. Why residual viremia persists with HAART (few copies only) ? • Viral production by infected cells not undergoing lytic cell death • Decay kinetic with a flat phase 3 • Long lived cells • Virus released when cells divide • Central memory CD4 T cells: TCR dependant • Transitional memory CD4 T cells: Homeostatic • T cell proliferation associated with T cell activation Mathusalem: 969 years old

  14. Role of T cell activation in the establishment and maintenance of reservoir Proliferation Activation Chomont et al Nat Med 2009 Da Fonseca et al IAS MOPE082

  15. Factors associated with CD4 T cellactivation may impact reservoir size LDL LDL Corbeau P, J Reynes, Blood 2011; 117:5582 adapted

  16. What are the relative contribution of mechanisms associated with HIV persistence on HAART ?

  17. Obstacle to HIV eradication

  18. Timing of HAART initiation and the reservoir size and localization • Limiting the pool of latently infected cells • Preserving immune functions • Reducing gut associated lymphoid tissue damage and in turn limiting subsequent inflammation triggered by systemic leakage of microbial products • Can this strategy be implemented on a large scale ?

  19. CD4/CD8 ratio and duration of viremia drive the reservoir size Chomontet al. Nat Med June 2009

  20. HAART intensification • Can HAART intensification completely suppress residual viral replication ? • Is there a threshold for a functionally important decay of the latent reservoir following intensified HAART ? • How long should we intensified treatment before assessing reservoir changes

  21. Long-lived CD4 T cells:The Trojan Horse issue • Mechanisms involved in the generation and maintenance of memory CD4 T cells are also responsible for the establishment and persistence of HIV in the long-lived cellular compartment “Do not trust the Horse, Trojans Whatever it is, I fear the Greeks even bearing gifts” Laocoonte, Vatican Museum

  22. Tools to monitors reservoir changes • Type of tests: • Ultra sensitive plasma viral load (RNA) • HIV DNA: integration • 2-LTR: replication • Integrated DNA infectious units • Cell associated RNA • Validation • Frequency of sampling

  23. Tissue sampling for monitoring of HIV persistence • Blood: • Leukapheresis • Lymph nodes • Gut: • Rectum, colon, ileum • Central nervous system: • CSF • Genital fluids

  24. Ethical and clinical trial issues • Toxicity of experimental therapy(ies) • Drug-drug interaction • Reservoir assessment: • Tissue markers • HAART discontinuation as a read out for study outcome • Quality of the informed consent • Study design

  25. “Higher risk, higher hope”

  26. Conclusion • Key topic at the Rome IAS conference • Translational research challenge • Community participation • International collaboration

  27. Université de Montréal: Patricia Montéro Annie Gosselin Petronela Ancuta Cécile Tremblay Rejean Thomas Benoit Trottier Jean–Guy Baril Harold Dion VGTI Florida Rafick Sékaly Nicolas Chomont Cytheris: IL-7 Michel Morre Thérèse Croughs Université McGill: Rachid Boulassel Bertrand Lebouché Roger LeBlanc Richard Lalonde Marina Klein Martin Potter Alexanda de Pokomandi Norbert Gilmore Mark Wainberg CIHR/CTN: Joel Singer Jacquie Sas Jo Pankovich David Cox Acknowledgement

  28. T cell survival and homeostatic proliferation Chomont, Sekaly et al Curr opin in HIV AIDS 2011;6: 30

  29. Model for persistent infection in hematopoietic progenitor cells Mcnamara et al Curr Opin HIV AIDS 2010; 6:43

  30. Diversité des formes du réservoir viral: Cellules latentes et productives

  31. Cohen J Science; 2011; 332:784

More Related